Press Release: MAPS Places Fully Validated, Multi-Kilogram Synthesis of MDMA in the Public Domain?
Cannabis Law Report
APRIL 21, 2022
As we approach our anticipated FDA approval in 2023, the availability of cGMP-compliant MDMA will be secured for future therapeutic use. This cGMP-compliant production process will supply the ongoing Phase 3 and investigator-initiated trials and will ameliorate existing supply constraints for the broader research community.
52 
Let's personalize your content